GERN Competitors & Alternatives
Compare Geron Corporation with similar stocks in the same industry
Biotechnology
GERN
Main Stock$1.35
Tradestie Score
45
Market Cap
$899.60M
Revenue Growth
0.2%
Analyst Upside
+214.8%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BCAX
Bicara Therapeutics Inc. Common Stock
|
$22.81
|
$906.29M | - | 51 | Compare |
|
NBTX
Nanobiotix S.A. American Depositary Shares
|
$37.01
|
$903.54M | - | 46 | Compare |
|
ORKA
Oruka Therapeutics, Inc. Common Stock
|
$92.38
|
$900.91M | - | 63 | Compare |
|
ANAB
AnaptysBio, Inc. Common Stock
|
$53.87
|
$894.30M | - | 46 | Compare |
|
TNGX
Tango Therapeutics, Inc.
|
$23.78
|
$887.30M | - | 60 | Compare |
|
ABUS
Arbutus Biopharma Corporation Common Stock
|
$5.12
|
$879.90M | 6.5 | 47 | Compare |
|
PHAT
Phathom Pharmaceuticals, Inc. Common Stock
|
$8.36
|
$871.90M | - | 50 | Compare |
|
TSHA
Taysha Gene Therapies, Inc. Common Stock
|
$5.02
|
$867.49M | - | 45 | Compare |
|
FTRE
Fortrea Holdings Inc. Common Stock
|
$17.20
|
$864.42M | - | 46 | Compare |
|
CRMD
CorMedix Inc.
|
$7.83
|
$862.55M | 3.7 | 41 | Compare |
More GERN Analysis
Data updated: Sep 12, 2026 | Industry: Biotechnology (SIC 2834)
236 stocks in this industry